The only new regulatory item in today's emergency sweep is a supplemental approval on 14 August for a generic buprenorphine and naloxone combination from Dr Reddy's Laboratories under ANDA 205299. The enforcement feed returned nothing.
The significance is about access rather than pharmacology. Buprenorphine-naloxone initiation from the emergency department is one of the better-evidenced interventions in opioid use disorder, and the barriers to it are consistently supply, cost and prescriber willingness rather than efficacy. Additional generic manufacturing capacity, particularly from an Indian manufacturer, addresses the first two. It does not address the third, which is the one departments control.
Also landing this week are the American College of Emergency Physicians' unscheduled procedural sedation Delphi consensus guidelines, published in two parts and approved by the ACEP board in April 2026 — Part 1 on principles, oversight and quality monitoring, and Part 2 on clinical practice. The published abstracts are the journal's standard policy disclaimer rather than a summary, so the substance is in the full documents, which are worth the time if your department's sedation policy predates them.
What this sweep does not see is worth stating. It watches FDA drug approvals and enforcement actions only. Device advisories, ACEP, SCCM and ESICM statements issued as web pages, ISCCM guidance, and CDSCO notices do not appear here at all, and on most days the guidance that would actually change an emergency department's practice is in one of those.
- Note expanding generic supply of buprenorphine-naloxone, which addresses cost and availability but not prescriber willingness
- Emergency department initiation of buprenorphine remains among the better-evidenced interventions in opioid use disorder
- Review your procedural sedation policy against the new two-part ACEP consensus guidelines if it has not been updated recently
- Read the ACEP documents themselves — the published abstracts carry a disclaimer, not a summary
- Remember the blind spots: device advisories, society web guidance, ISCCM and CDSCO notices are outside this feed
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.
Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for emergency & critical care, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free